A pair of position papers released by the Racing Medication and Testing
Consortium (RMTC) find no physiologic difference in the various racing
breeds to justify changes to its established regulatory thresholds for
use of clenbuterol and corticosteroids.
The papers are the conclusions of a panel formed at the request of the United States Trotting Association (USTA) which, at the September RMTC meeting, called for more liberal thresholds for the use of intra-articular corticosteroids and clenbuterol in Standardbreds. Following that meeting, the USTA ended its RMTC membership, citing difference in breeds.
continue to read here
The papers are the conclusions of a panel formed at the request of the United States Trotting Association (USTA) which, at the September RMTC meeting, called for more liberal thresholds for the use of intra-articular corticosteroids and clenbuterol in Standardbreds. Following that meeting, the USTA ended its RMTC membership, citing difference in breeds.
continue to read here
No comments:
Post a Comment